Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Avidity Biosciences (RNA) Shares Outstanding (Diluted Average): 2020-2025

Historic Shares Outstanding (Diluted Average) for Avidity Biosciences (RNA) over the last 5 years, with Sep 2025 value amounting to $137.9 million.

  • Avidity Biosciences' Shares Outstanding (Diluted Average) rose 11.77% to $137.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $137.9 million, marking a year-over-year increase of 11.77%. This contributed to the annual value of $111.6 million for FY2024, which is 52.83% up from last year.
  • Per Avidity Biosciences' latest filing, its Shares Outstanding (Diluted Average) stood at $137.9 million for Q3 2025, which was up 6.38% from $129.6 million recorded in Q2 2025.
  • Over the past 5 years, Avidity Biosciences' Shares Outstanding (Diluted Average) peaked at $137.9 million during Q3 2025, and registered a low of $37.6 million during Q2 2021.
  • Over the past 3 years, Avidity Biosciences' median Shares Outstanding (Diluted Average) value was $106.9 million (recorded in 2024), while the average stood at $101.3 million.
  • Data for Avidity Biosciences' Shares Outstanding (Diluted Average) shows a peak YoY soared of 91.24% (in 2021) over the last 5 years.
  • Quarterly analysis of 5 years shows Avidity Biosciences' Shares Outstanding (Diluted Average) stood at $41.4 million in 2021, then grew by 25.91% to $52.2 million in 2022, then surged by 39.97% to $73.0 million in 2023, then soared by 52.83% to $111.6 million in 2024, then climbed by 11.77% to $137.9 million in 2025.
  • Its Shares Outstanding (Diluted Average) stands at $137.9 million for Q3 2025, versus $129.6 million for Q2 2025 and $129.2 million for Q1 2025.